| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.00099 | 1 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.00054 | 1 |